Iyuda Therapeutics, Inc. — Form D
Iyuda Therapeutics, Inc. of Owings Mills, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-14. The offering totals $343K, of which $343K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-14
- Form: D
- Accession: 0001993594-23-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $343K
- Amount sold: $343K
- Minimum investment: $12K
- Investors: 4
- Date of first sale: 2023-08-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-492130
Issuer
- Name: Iyuda Therapeutics, Inc.
- CIK: 0001993594
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3217 Hunting Tweed Dr., Owings Mills, MD, 21117
- Phone: 202-913-8697
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Robert Tennant | Executive Officer | Owings Mills, MD |
| Robert Tennant | Related Person | Owings Mills, MD |
| Ephraim Fuchs | Director | Owings Mills, MD |
| Ephraim Fuchs | Related Person | Owings Mills, MD |
Other filings by this issuer (5)
More